{"id":"W7116858522","doi":"10.1016/s1470-2045(25)00566-2","title":"Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Bristol-Myers Squibb","keywords":"Docetaxel; Prostate cancer; Placebo; Nivolumab; Androgen receptor; Enzalutamide; Clinical trial; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001725642,0.002247857,0.003612538,0.0005106586,0.0005643019,0.001290078,0.001332372,0.002209914,0.008322403],"category_scores_gemma":[0.00187939,0.001005769,0.002704405,0.000437353,0.001582974,0.001299001,0.0004832248,0.003846788,0.001452695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001058291,"about_ca_system_score_gemma":0.00122988,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00248551,"about_ca_topic_score_gemma":0.005161802,"domain_scores_codex":[0.9993088,0.0003594462,0.00003651088,0.0001408632,0.00004388033,0.0001106262],"domain_scores_gemma":[0.9992077,0.0002733747,0.000141362,0.00006127496,0.00004841676,0.0002680117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9890209,0.002406029,0.0001165546,0.0003801905,0.0005218586,0.00001209219,0.00002871744,0.0002021111,0.0006862926,0.00006682827,0.0003881708,0.006170269],"study_design_scores_gemma":[0.967389,0.03124366,0.0004177127,0.00002168142,0.0002391061,0.000010208,0.00001366782,0.000236948,0.0001141739,0.00009802447,0.0002054574,0.00001048104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9824829,0.006446936,0.0007646415,0.0006845161,0.001430272,0.004331634,0.001089026,0.000219386,0.002550621],"genre_scores_gemma":[0.9830068,0.003287687,0.001516281,0.001035206,0.0005958823,0.003389693,0.0009387315,0.00004567806,0.006184014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008322403,"threshold_uncertainty_score":0.02784115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1042693997009189,"score_gpt":0.4213432327201574,"score_spread":0.3170738330192385,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}